This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

ChinaBio® Partnering Forum

$500 savings end in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Kerry Hotel Pudong
April 23–24, 2025 | Shanghai, ChinaApril 29–30, 2025 | Virtual

Helen Chen
Global Sector Co-Head, Healthcare & Life Sciences at L.E.K. Consulting
Speaker

Profile

Helen Chen is Global Sector Co-Head for Healthcare and a Greater China Managing Partner of L.E.K. Consulting based in Shanghai. Helen was a member of L.E.K.’s Global Leadership Team from 2012 to 2016. She is also a Director of the firm’s Asia-Pacific Life Sciences Centre of Excellence. Helen was named one of Consulting magazine’s Global Leaders in Consulting in 2019.

Helen has over 30 years of consulting and industry experience in the U.S. and Asia markets and has lived in China since 2000. She helps companies expand their presence in China and Asia, and leverages Asia’s innovation to improve their global businesses. For companies anchored in China, Helen advises on their drive to innovation and globalization. Helen is a frequent speaker and author on the opportunities and issues in China’s healthcare and life sciences sectors. Her expert commentary has appeared in Bloomberg, Financial Times, The Wall Street Journal, Forbes Asia and the South China Morning Post, and in several industry publications, including BioCentury, In Vivo, Script and BioWorld.

Prior to joining L.E.K., Helen held senior management roles at several technology companies in the U.S. and China. She was an associate director of finance at Genentech (now Roche) and a sales planner at Abbott Laboratories (now Abbvie). Helen has an honors B.A. degree in Applied Mathematics from Harvard University.


Agenda Sessions

  • Ascentage Pharma's Dual-Listing Journey - Pioneering Chinese Biotech on the Global Stage

    13:30